SCM
CABA icon

Superstring Capital Management’s Cabaletta Bio CABA Stock Holding History

Superstring Capital Management’s Portfolio CABA Stock Details CABA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$3.48M Buy
1,278,652
+212,413
+20% +$699K 2.2% 19
2026
Q1 		$2.87M Sell
1,066,239
-1,187,311
-53% -$3.3M 2.05% 22
2025
Q4 		$4.94M Buy
2,253,550
+709,025
+46% +$1.76M 2.64% 14
2025
Q3 		$3.61M Buy
1,544,525
+483,761
+46% +$830K 3.56% 12
2025
Q2 		$1.61M Buy
1,060,764
+601,792
+131% +$938K 1.91% 18
2025
Q1 		$636K Sell
458,972
-363,321
-44% -$774K 0.76% 27
2024
Q4 		$1.87M Buy
822,293
+690,498
+524% +$2.42M 1.62% 18
2024
Q3 		$622K Sell
131,795
-8,100
-6% -$46.9K 0.54% 23
2024
Q2 		$1.05M Sell
139,895
-150,902
-52% -$1.85M 1.32% 22
2024
Q1 		$4.96M Buy
+290,797
New +$6.24M 3.28% 12

Other funds holding CABA

Jennison Associates
Jennison Associates New York $167B AUM 44.17% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return
BCLSI
Bain Capital Life Sciences Investors Boston, Massachusetts $1.68B AUM 126.09% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $71.3B AUM 56.8% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
CAM
Cormorant Asset Management Boston, Massachusetts $1.95B AUM 773.9% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
WP
Woodline Partners San Francisco, California $32.4B AUM 58.5% 1-Year Est. Return

Superstring Capital Management's CABA Position: Q2 2026 in Review

Superstring Capital Management increased its Cabaletta Bio (CABA) stake by 20% in Q2 2026, buying an estimated $699K and bringing the position to 1,278,652 shares worth $3.48M. The position accounts for 2.2% of the portfolio, ranked #19.

Superstring Capital Management first reported a position in CABA in Q1 2024 and has held it in 10 quarters since. The position peaked at $4.96M in Q1 2024. 140 funds tracked by Wall St. Rank hold CABA as of Q2 2026.

  • Superstring Capital Management held 1,278,652 shares of Cabaletta Bio worth $3.48M as of Q2 2026.
  • Superstring Capital Management bought 212,413 Cabaletta Bio shares in Q2 2026, an estimated $699K.
  • Cabaletta Bio made up 2.2% of Superstring Capital Management's portfolio in Q2 2026, its #19 holding.
  • Superstring Capital Management first reported a position in Cabaletta Bio in Q1 2024 and has held it in 10 quarters since.
  • Superstring Capital Management's Cabaletta Bio position peaked at $4.96M in Q1 2024.
  • 140 funds tracked by Wall St. Rank held Cabaletta Bio as of Q2 2026.

Based on Superstring Capital Management's 13F filing for Q2 2026, filed 14 Aug 2026.